Status:
TERMINATED
Smoking Cessation Treatment for Head and Neck Cancer Patients
Lead Sponsor:
Yale University
Conditions:
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
This is a pilot research study examining the use of varenicline (Chantix) and the nicotine patch. The study is designed to find out whether one of these medications is more effective for smoking cessa...
Eligibility Criteria
Inclusion
- age 18 or older
- smoking 10 or more cigarettes per day
- diagnosed with and completed an initial course of treatment for any type of head and neck cancer
- life expectancy of 12 months or more
Exclusion
- history of allergic reactions to adhesives
- unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis, severe alcohol dependence, or dementia
- females of childbearing potential who are pregnant, nursing, or not practicing effective contraception
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00931021
Start Date
July 1 2009
End Date
December 1 2012
Last Update
July 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University School of Medicine
New Haven, Connecticut, United States, 06511